Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 11;11(1):454.
doi: 10.1186/s13104-018-3586-0.

Effects of lyophilization and storage temperature on Wuchereria bancrofti antigen sensitivity and stability

Affiliations

Effects of lyophilization and storage temperature on Wuchereria bancrofti antigen sensitivity and stability

Edem Y Agbozo et al. BMC Res Notes. .

Abstract

Objective: Antigen-based rapid diagnostic tests for Lymphatic filariasis (LF) do not come with external quality control (QC) materials, and research and disease control programmes rely on stored positive samples. This study was undertaken to evaluate the use of lyophilized Wuchereria bancrofti antigen positive plasma samples to serve as QC materials for LF diagnostic tests. 10 well characterized W. bancrofti positive samples were lyophilized and stored at 4, 28 and 40 °C. The samples were evaluated using the Alere Filariasis Test Strips before lyophilization, and after 1 and 3 months of storage. The sensitivity and stability of the lyophilized samples were evaluated.

Results: The results revealed a loss of sensitivity and stability with increasing temperature and duration of storage. The results are further discussed in terms of the use of dried blood spot (DBS) in diagnostic studies on LF, and the need for thoughtful DBS preparation and storage.

Keywords: Dried blood spots; Freeze-drying; Lyophilization; Wuchereria bancrofti antigen.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Change in antigen stability with temperature and storage time. Error bars represent the standard errors of the mean. * denotes significance compared to baseline (p < 0.01)

Similar articles

Cited by

References

    1. WHO Global programme to eliminate lymphatic filariasis: progress report, 2016. Wkly Epidemiol Rec. 2017;92:589–608. - PubMed
    1. Ottesen EA. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol. 2006;61:395–441. doi: 10.1016/S0065-308X(05)61010-X. - DOI - PubMed
    1. Ottesen EA, Duke BO, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ. 1997;75(6):491–503. - PMC - PubMed
    1. WHO . Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. WHO/HTM/NTD/PCT/2011. Geneva: WHO; 2011. pp. 1–79.
    1. WHO . Guideline—alternative mass drug administration regimens to eliminate lymphatic filariasis. WHO/HTM/NTD/PCT/2017. Geneva: WHO; 2017. - PubMed

Substances

LinkOut - more resources